Dictionary

allow_url_fopen is ENABLED Dictionary Search

actinium

Synonyms

Noun

1. Ac

2. atomic number 89, chemical element, element

Usage
Pennsylvania to house new actinium-225 manufacturing facility - European Pharmaceutical Review
TerraPower Isotopes Invests $450M in Actinium-225 Production Facility - Oncodaily
TerraPower Commits $450M to Build Radioisotope Production Plant - BioSpace
Gates-backed TerraPower Isotopes blueprints $450M plant to supply next wave of radiopharmaceuticals - Fierce Pharma
Bill Gates-founded nuclear company invests $450M in South Philly facility - Axios
Actinium Pharmaceuticals to Unveil the Multi-Tumor Potential of ATNM-400, a First-in-Class Actinium-225 Radiotherapy, with Data in Non-Small Cell Lung Cancer at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeut - PR Newswire
$450 million cancer-fighting isotope manufacturing facility coming to Philly - NBC10 Philadelphia
Laser spectroscopy and CP-violation sensitivity of actinium monofluoride - Nature
Actinium Pharmaceuticals, Inc. to Present Two Abstracts at the 2026 AACR Annual Meeting - Yahoo Finance
ASCO 2025: PSMA-Targeted Actinium-225 Therapy in Metastatic Castration-Resistant Prostate Cancer (mCRPC): Baseline and Follow-up PSMA PET Parameters Associated with Outcomes - UroToday
Actinium Pharmaceuticals Presents New Data Demonstrating Potent and Durable Efficacy of ATNM-400, a First-in-Class Multi-Tumor Actinium-225 Radiotherapy, at the 32nd Annual Prostate Cancer Foundation Scientific Retreat - PR Newswire
Jeri Kim: Thrilled to Join Actinium Pharmaceuticals as VP, Head of Solid Tumor Clinical Development - Oncodaily
Radiopharma Sector Races To Secure Actinium-225 Supply as Pipelines Expand - BioSpace
High-energy resolution X-ray spectroscopy reveals bonding characteristics of La - Nature
Actinium Pharmaceuticals Announces ATNM-400 Data Demonstrating Potent Efficacy in Triple-Negative Breast Cancer and Ability to Overcome Endocrine and HER2-Targeted Therapy Resistance Being Presented at the San Antonio Breast Cancer Symposiu - PR Newswire
Actinium Announces Superior Anti-Tumor Activity of ATNM-400 in Lung Cancer Compared to the Leading First, Second and Third-Line Approved EGFR Mutant Therapies and Mechanistic Synergy with Osimertinib at the AACR-NCI-EORTC International Confer - PR Newswire
Actinium to Present ATNM-400 Preclinical Data Highlighting Durable Tumor Control and Ability to Overcome Resistance to Standard-of-Care Prostate Cancer Therapies at the 32nd Annual Prostate Cancer Foundation Scientific Retreat - PR Newswire
Actinium Pharmaceuticals Presents New Preclinical Data Demonstrating Potent Anti-Tumor Activity of ATNM-400 Across Multiple Breast Cancer Subtypes Including Hormone Receptor-Positive, Triple-Negative, and Tamoxifen- and HER2 Therapy-Resistant Br - PR Newswire
Actinium Pharmaceuticals, Inc. to Participate in the Stephens Biotechnology Virtual Fireside Chat Conference - PR Newswire
Actinium Pharmaceuticals, Inc. to Highlight ATNM-400 Data in Hormone-Resistant and HER2-Resistant Breast Cancer at the 2025 San Antonio Breast Cancer Symposium, Expanding Pan-Tumor Profile Across Three Solid Tumor Indications - PR Newswire
Novartis prunes its pipeline | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline
Are Medical Stocks Lagging Actinium Pharmaceuticals (ATNM) This Year? - Yahoo Finance
Actinium Presents Data Supporting Paradigm Changing Potential of ATNM-400 in Prostate Cancer Demonstrating Its Superior Efficacy and Improved Survival in Treatment Resistant Tumor Models versus Pluvicto and ARPI Therapy, and Also Enhanced Efficac - PR Newswire
Belgium’s PanTera Begins Construction Of Dedicated Actinium-225 Facility - NucNet
Actinium Highlights Expanded Data Set for ATNM-400 in Prostate Cancer Demonstrating Superior Efficacy to Enzalutamide and Ability to Overcome Resistance to ARPI Therapy and PSMA-Ac-225/Lu-177 Labelled Radiotherapy at the Society of Nuclear Medic - PR Newswire
Phase 1 Trial of an Actinium-Labeled KLK2-Targeting Antibody for mCRPC - Michael Morris - UroToday
The Race for the Global Radiotherapy Cancer Market; Actinium Pharmaceuticals' (ATNM) Big Bet - TMX Newsfile
Comparing Lead-212 and Actinium-225 Alpha Emitters for Prostate Cancer Treatment "Presentation" - Alfred Morgenstern - UroToday
Niowave and Novartis Enter Global Actinium-225 Supply Agreement to Advance Next-Generation Cancer Therapies - Yahoo Finance
How Eckert & Ziegler’s Actinium-225 Radio-DARPin Partnership (XTRA:EUZ) Has Changed Its Investment Story - simplywall.st
Lilly misses its Point | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline
Actinium-PSMA J591 After Prior Lutetium Therapy in Metastatic Prostate Cancer - Scott Tagawa - UroToday
Is Actinium Pharmaceuticals (ATNM) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Niowave Expands Global Supply Agreement with AstraZeneca to Deliver Actinium-225 for Next-Generation Cancer Therapies - PR Newswire
Stibbe assists PanTera with the development of its Actinium Production Center - stibbe.com
SK biopharmaceuticals secures European supply of actinium-225 through deal with Germany's Eckert & Ziegler - koreabiomed.com
ORNL Commits to Targeted Alpha Therapy - Mirage News
Novartis taps Niowave for supply of radiopharmaceutical isotope - Fierce Pharma
Ratio Therapeutics and TerraPower Isotopes Sign Supply Agreement for Actinium-225 For Targeted Radiotherapeutics - PR Newswire
AstraZeneca locks in long-term actinium-225 supply with Niowave - The Pharma Letter
New NIST Standard Helps Deliver the Right Dosage of Cancer-Fighting Drugs - National Institute of Standards and Technology (.gov)
Actinium Announces Enrollment of First Patient in the Iomab-ACT Commercial CAR-T Trial at the University of Texas Southwestern Medical Center - PR Newswire
Actinium Pharmaceuticals stock rises after promising breast cancer therapy data - Investing.com
UCLA Health launches novel clinical trial for recurrent prostate cancer - UCLA Health
Novartis Actinium 225 Deal Supports Radioligand Focus And Valuation Case - Yahoo Finance
Preclinical data show promise of ATNM-400 for prostate cancer - Urology Times
Why Is Actinium Pharmaceuticals Stock Rising Today? - Stocktwits
SK Biopharm secures Actinium-225 supply in Europe with Eckert & Ziegler deal - The Korea Herald
AtomVie Global Radiopharma and TerraPower Isotopes Announce Strategic Supply Agreement for Actinium-225 to Advance Radiopharmaceutical Development and Manufacturing - PR Newswire
First Patient With Breast Cancer Dosed With Novel Radioactive Medicine - Cure Today
Actinium Presents Data Showing ATNM-400 is More Efficacious than Pluvicto and is Highly Efficacious after Pluvicto Resistance in Prostate Cancer Tumor Models at the American Association for Cancer Research Annual Meeting - PR Newswire
Mayo Clinic treats first person in the US with a novel radiopharmaceutical therapy for breast cancer - Mayo Clinic News Network
Actinium’s biology-driven cancer radiotherapy work featured at AACR 2026 - Stock Titan
BIOEMTECH and NorthStar Medical Radioisotopes Announce Strategic Supply Agreement for Actinium-225 to Support Preclinical Radiopharmaceutical Research - Business Wire
Radium sources yield cancer-fighting Ac-225 in IAEA program - American Nuclear Society -- ANS
Actinium Pharmaceuticals, Inc. Announces Principal Financial Officer Changes, Effective as of February 27, 2026 - marketscreener.com
Safety and Activity of Alpha-Emitting Ac-225-PSMA-617 Radioligand Therapy in mCRPC That Has Progressed After Lu-177-PSMA, Journal Club – Christopher Wallis & Zachary Klaassen - UroToday
Bayer initiates Phase I study targeting GPC3 with actinium-225 radiopharmaceutical in patients with advanced hepatocellular carcinoma - Bayer
New radioactive isotope therapies promise more targeted attacks on cancer - Science | AAAS
Clinical Experience with Actinium-PSMA Across Multiple Treatment Centers "Presentation" - Alfred Morgenstern - UroToday
NorthStar Medical Radioisotopes Confirms Successful Routine Commercial-scale Ac-225 Production - BioSpace
Radioactive protein drugs take aim at small cell lung cancer tumors - Stock Titan
Cellectar (NASDAQ: CLRB) secures Ac-225, At-211 supply for CLR-225 targeted alpha trials - Stock Titan
Cellectar Biosciences Announces Strategic Supply Agreement - GlobeNewswire
Niowave And Novartis Enter Global Actinium-225 Supply Agreement To Advance Next-Generation Cancer Therapies - TradingView
Actinium Pharmaceuticals Provides Business Update After Presentation at Trump Mar-A-Lago Club Announcing Novel Non-PSMA Prostate Cancer Radiotherapy ATNM-400 and Outlining Revitalized Clinical Pipeline with 2025 Corporate Objectives - PR Newswire
Niowave to supply actinium-225 to Novartis under long-term agreement - DOTmed
Ratio, Ionetix ink separate deals to speed production of in-demand radiopharmaceutical isotopes - Fierce Pharma
Surge in Radiopharmaceutical R&D Puts Pressure on Unique Supply Chain - BioSpace
Actinium Pharmaceuticals to Present Business Update at Trump Mar-A-Lago Club Today - PR Newswire
Actinium Pharmaceuticals Advances ATNM-400 B7-H3 Candidate Into Phase 1 Clinical Trial in South Africa - openPR.com
Versatile Bifunctional PYTA Derivatives for 225Ac Radiolabeling: A Comparison to Gold Standards - Journal of Nuclear Medicine
225Actinium PSMA-617 and 177Lutetium PSMA-617 Tandem Therapy in mCRPC Patients, Journal Club – Christopher Wallis & Zachary Klaassen - UroToday
BMS's RayzeBio unit opens $160M radiopharma plant in Indianapolis - FirstWord Pharma
Actinium Pharmaceuticals Announces ATNM-400 a Novel Non-PSMA Targeting First in Class Prostate Cancer Radiotherapy Leveraging Actinium-225 - PR Newswire
IONETIX Corporation and AlfaRim Medical B.V. announce a strategic partnership to fast-track commercial production of Actinium-225 - PR Newswire
Medical Radioisotopes and Stable Isotope Surge - Mirage News
Actinium Pharmaceuticals Announces Supply Agreement with Eckert & Ziegler for Ac-225 Radioisotope to Support Comprehensive Development Activities - PR Newswire
Botulinum Toxin and Scopolamine for Radiation-Induced Salivary Gland Toxicity in Metastatic Prostate Cancer - The ASCO Post
regulatory T cells synergizes with immunotherapy to promote tumor rejection in syngeneic colorectal cancer models - Frontiers
Actinium-225 illustration with cancer cell and alpha radiation - National Institute of Standards and Technology (.gov)
Actinium Highlights ATNM 400 Progress at SNMMI Conference - Finviz
Actinium Pharmaceuticals, Inc. to Present Two Abstracts at the 2026 AACR Annual Meeting - Finansavisen
Bayer Initiates Phase I Study Targeting GPC3 With Actinium-225 Radiopharmaceutical in Patients With Advanced Hepatocellular Carcinoma - Business Wire
Patented technology removes key radioactive contaminant in critical minerals processing - ANSTO
AtomVie Global Radiopharma and TerraPower Isotopes Announce Strategic Supply Agreement for Actinium-225 to Advance Radiopharmaceutical Development and Manufacturing - PA Media
Actinium launches ATNM-400 radiotherapy for prostate cancer treatment - AuntMinnie
Bristol Myers Squibb Is Paying $350M to Expand Its Reach in Radiopharmaceuticals to Prostate Cancer - MedCity News
Ac and other radionuclidic impurities in mass-separated - Nature
Actinium chelation and crystallization in a macromolecular scaffold - Nature
Stability as a Strategic Asset in Biotech's Turbulent Climate - AD HOC NEWS
ACCEL Trial Tests Actinium-225-PSMA-62 in Prostate Cancer - Ramy Saleh - UroToday
Novartis goes earlier with actinium | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline
TerraPower Isotopes Brings Actinium-225 to Market - TerraPower
Caught in the Actinium - Berkeley Lab News Center (.gov)
From warhead to cancer-killer, the quest for more actinium-225 - Drug Discovery News
Actinium Pharmaceuticals, Inc. to Participate in the Stephens Biotechnology Virtual Fireside Chat Conference - Finansavisen
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Actinium - StreetInsider
Shareholders that lost money on Actinium Pharmaceuticals, Inc. (A - The National Law Review
Is Actinium Really Happening? - Journal of Nuclear Medicine
Foreign Language Equivalents
Foreign Language Equivalents of 'actinium'
Language Equivalent   Language Equivalent
French actinium    Spanish
Misspellings - Typos
actinim,   actiniium,   actiinum,   actunium,   acinium,   aactinium,   actiniim,   actiniumm,   acyinium,   avtinium,   actiniu,,   actniium,   atinium,   actiniym,   acttinium,   actiinium,   actimium,   catinium,   actinnium,   actiniun,   acctinium,   actibium,   actiniu,   acitnium,   axtinium,   actinuum,   actinuim,   actiniuum,   actnium,   actinoum,   atcinium,   actinimu,   acrinium,   actinum,   actonium,   ctinium,   actiium,   sctinium
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z